Heart Disease News and Research

Latest Heart Disease News and Research

Childhood adversity associated with morbidity and mortality in the U.S.

The findings of a new study suggest that childhood adversity is a major contributor to early and preventable causes of mortality and a powerful determinant of long term physical and mental health.

12 Oct 2021

Using genetic screening for selecting the 'best' embryo in IVF

Each year, tens of thousands of babies are born in the United States as the result of IVF (in vitro fertilization) – where several eggs are fertilized outside the mother's body and then an embryo is selected for transfer into her womb.

12 Oct 2021

International meeting focuses on screening, early and personalized treatment for atrial fibrillation

Screening, early treatment, and personalized therapy for atrial fibrillation are on the agenda of an international meeting starting today.

12 Oct 2021

Newly discovered molecule could be used to prevent collateral harm to vital organs during surgery

A newly detected molecule that helps reduce damage from sustained loss of blood flow to cells and tissues could eventually be used to prevent collateral harm to vital organs during surgery, according to University of Utah Health scientists.

11 Oct 2021

Drug developed at Duke is approved by FDA as only therapy for congenital athymia

The phone rang into the pediatric unit that Louise Markert, M.D., Ph.D., was staffing as a junior faculty member in 1991. Had she not answered, there would have been little hope for the more than one hundred patients who were subsequently treated.

11 Oct 2021

An investigation of SARS-CoV-2 infection in diabetic pregnancies

Researchers discuss the basic and clinical science of the potential inter-relationships between diabetes mellitus and COVID-19 in pregnancies.

11 Oct 2021

New machine-learning model can identify individuals at risk of rare cardiomyopathy

A machine-learning model can identify patients at risk of a rare cardiomyopathy, according to a study published in Nature Communications.

11 Oct 2021

Formal health care transition programs needed to provide uninterrupted support for youth with Kawasaki disease

Kawasaki disease is the most common cause of acquired heart disease that develops in early childhood, creating inflammation in blood vessels, particularly heart arteries.

11 Oct 2021

CDC and ClinGen partner to develop expert curated variant list for the genomic community

The Centers for Disease Control and Prevention's Genetic Testing Reference Material Program (GeT-RM) has partnered with the Clinical Genome Resource (ClinGen) to develop a publicly available list of 546 expert curated pathogenic variants in 84 genes for use in next-generation sequencing (NGS) genetic testing.

11 Oct 2021

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Researchers have investigated the differences between 'classic' myocarditis, COVID-19 induced myocarditis, and vaccine-related myocarditis.

11 Oct 2021

Sero-epidemiological insights into pathways to COVID-19 immunity

A new study posted to the medRxiv* server attempts to utilize serology as a tool to identify disparities in infection rates and vaccination coverage.

10 Oct 2021

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

The estimated incidence of myocarditis among patients that have received at least one dose of the Pfizer-BioNTech (BNT162b2) mRNA vaccine against coronavirus disease 2019 (COVID-19) was 2.13 cases per 100,000 persons, primarily affecting young men and presenting mostly as mild or moderate illness, as demonstrated by a recent study published in the New England Journal of Medicine.

10 Oct 2021

COVID-19 vaccination rates among minority populations

A new study discusses offers insights into how minority groups can be effectively persuaded to take the currently available COVID-19 vaccines.

10 Oct 2021

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Hospital admissions and deaths due to COVID-19 were drastically reduced at two weeks or more from the first dose of either the Pfizer or AstraZeneca vaccine.

10 Oct 2021

Researchers identify new biomarker for severe COVID-19

During the pandemic, it has become increasingly evident that people with cardiovascular disease and obesity are at a much higher risk of developing very severe, even fatal COVID-19 disease.

8 Oct 2021

New digital program to improve physical and mental wellbeing of young cancer survivors

A digital program enhancing physical and mental wellbeing for young people adjusting to life after cancer, will be developed by The University of Queensland in partnership with cancer support organisation Canteen.

8 Oct 2021

Study uncovers toxic air pollutant mixtures linked to poor childhood asthma outcomes

Researchers at the Icahn School of Medicine at Mount Sinai have developed a novel machine learning algorithm and used it to identify previously unknown mixtures of toxic air pollutants that appear to be linked to poor asthma outcomes later in a child's life.

8 Oct 2021

Experts address questions on psoriasis patients’ true needs and wellbeing

Almirall S.A., a global biopharmaceutical company focused on skin health, has hosted a scientific session during the 30th EADV Congress which addressed the need and importance to focus on patient wellbeing in real-life clinical practice.

8 Oct 2021

Study uncovers new drug target for myelodysplastic syndrome

Mount Sinai and UC San Diego researchers have shown for the first time how mutations affecting a cellular process called RNA splicing alter cells to develop myelodysplastic syndrome (MDS) and other hematologic malignancies and solid tumors, according to a study published in Cancer Discovery in October.

7 Oct 2021

Additional health care support needed to improve medication adherence among people with hypertension

People with hypertension, or high blood pressure, play a key role in whether they use medication appropriately to manage their blood pressure.

7 Oct 2021

Heart Disease News and Research

Latest Heart Disease News and Research

Childhood adversity associated with morbidity and mortality in the U.S.

Using genetic screening for selecting the 'best' embryo in IVF

International meeting focuses on screening, early and personalized treatment for atrial fibrillation

Newly discovered molecule could be used to prevent collateral harm to vital organs during surgery

Drug developed at Duke is approved by FDA as only therapy for congenital athymia

An investigation of SARS-CoV-2 infection in diabetic pregnancies

New machine-learning model can identify individuals at risk of rare cardiomyopathy

Formal health care transition programs needed to provide uninterrupted support for youth with Kawasaki disease

CDC and ClinGen partner to develop expert curated variant list for the genomic community

Better clinical outcomes in COVID-19 and vaccine-related myocarditis than classic myocarditis in children

Sero-epidemiological insights into pathways to COVID-19 immunity

Myocarditis after mRNA COVID vaccine extremely rare, most cases mild or moderate

COVID-19 vaccination rates among minority populations

Low risk of severe COVID-19 after first dose of Pfizer and AstraZeneca vaccines in Scotland

Researchers identify new biomarker for severe COVID-19

New digital program to improve physical and mental wellbeing of young cancer survivors

Study uncovers toxic air pollutant mixtures linked to poor childhood asthma outcomes

Experts address questions on psoriasis patients’ true needs and wellbeing

Study uncovers new drug target for myelodysplastic syndrome

Additional health care support needed to improve medication adherence among people with hypertension

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Heart Disease News and Research

Latest Heart Disease News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Newsletters you may be interested in